Deng, Chao <br/><br/>
What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?  [electronic resource] 

 -  Journal of clinical psychopharmacology  Aug 2010 
 - 480-1 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1533-712X 
<br/><br/><label>Standard No.: </label>10.1097/JCP.0b013e3181e74555  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--adverse effects<br/>Aripiprazole<br/>Benzodiazepines--adverse effects<br/>Controlled Clinical Trials as Topic<br/>Double-Blind Method<br/>Humans<br/>Obesity--chemically induced<br/>Olanzapine<br/>Piperazines--pharmacology<br/>Quinolones--pharmacology<br/>Schizophrenia--drug therapy<br/>Weight Gain--drug effects